Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Amicus Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Amicus Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Amicus Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Whitman Burke WDirector0Apr 27, 20261
McGlynn Margaret GDirector0Apr 27, 20261
Wheeler Craig ADirector0Apr 27, 20261
Sblendorio GlennDirector0Apr 27, 20261
Raab MichaelDirector0Apr 27, 20261
Campbell Bradley LPresident and CEO0Apr 27, 20267
Harford Simon N.R.Chief Financial Officer0Apr 27, 20262
Castelli JeffChief Development Officer0Apr 27, 20263
Bleil Lynn DorseyDirector0Apr 27, 20261
Rosenberg EllenChief Legal Officer0IndirectApr 27, 20263
Roberts EiryDirector0Apr 27, 20261
Prout SamanthaChief Accounting Officer0Apr 27, 20263
Clark David MichaelChief People Officer0Apr 27, 20266
Kelly Michael AaronDirector0Apr 27, 20261
Crowley John FExecutive Chairman927,013Mar 15, 20240
Quimi DaphneChief Financial Officer398,532Jan 19, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 4, 2026 (view filing)Mar 22 daysCampbell Bradley LPresident and CEOSSale−22.5K$14.35−$322.9K−2.2%998.7K after10b5-1
Jan 22, 2026 (view filing)Jan 202 daysCampbell Bradley LPresident and CEOSSale−75.0K$14.31−$1.07M−6.8%1.02M after10b5-1
Dec 23, 2025 (view filing)Dec 194 daysClark David MichaelChief People OfficerSSale−25.6K$14.17−$363.3K−9.5%245.7K after10b5-1
Dec 17, 2025 (view filing)Dec 152 daysCampbell Bradley LPresident and CEOSSale−77.9K$10.86−$846.3K−6.5%1.13M after10b5-1
Dec 17, 2025 (view filing)Dec 152 daysClark David MichaelChief People OfficerSSale−25.6K$11.00−$282.1K−8.6%271.3K after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysCampbell Bradley LPresident and CEOSSale−14.6K$10.01−$146.0K−1.3%1.14M after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysCastelli JeffChief Development OfficerSSale−76.2K$10.16−$773.8K−14.8%439.3K after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysClark David MichaelChief People OfficerSSale−25.6K$10.10−$259.0K−7.9%297.0K after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysCampbell Bradley LPresident and CEOSSale−14.6K$10.04−$146.5K−1.3%1.14M after10b5-1
Nov 26, 2025 (view filing)Nov 24-262 daysRosenberg EllenChief Legal OfficerSSale−95.6K$10.02−$958.4K−15.8%507.7K after3 lots10b5-1
Nov 5, 2025 (view filing)Nov 41 dayClark David MichaelChief People OfficerSSale−25.6K$9.51−$243.9K−7.4%322.6K after10b5-1
Feb 21, 2025 (view filing)Feb 192 daysCampbell Bradley LPresident and CEOSSale−400$10.00−$4.00K0.0%1.15M after10b5-1
Dec 3, 2024 (view filing)Dec 21 dayCampbell Bradley LPresident and CEOSSale−7.50K$10.02−$75.2K−0.8%886.7K after10b5-1
Nov 7, 2024 (view filing)Nov 61 dayCampbell Bradley LPresident and CEOSSale−7.90K$12.50−$98.8K−0.9%886.7K after10b5-1
Nov 4, 2024 (view filing)Nov 13 daysCampbell Bradley LPresident and CEOSSale−7.50K$11.46−$86.0K−0.8%886.7K after10b5-1
Oct 4, 2024 (view filing)Oct 13 daysLateCampbell Bradley LPresident and CEOSSale−7.50K$10.60−$79.5K−0.8%886.7K after10b5-1
Sep 5, 2024 (view filing)Sep 32 daysCampbell Bradley LPresident and CEOSSale−7.50K$11.71−$87.8K−0.8%886.7K after10b5-1
Aug 5, 2024 (view filing)Aug 14 daysCampbell Bradley LPresident and CEOSSale−7.50K$10.34−$77.5K−0.8%886.7K after10b5-1
Jul 9, 2024 (view filing)Jul 54 daysCampbell Bradley LPresident and CEOSSale−6.10K$10.00−$61.0K−0.7%886.7K after10b5-1
Jul 3, 2024 (view filing)Jul 12 daysCampbell Bradley LPresident and CEOSSale−1.40K$10.00−$14.0K−0.2%886.7K after10b5-1
Jun 5, 2024 (view filing)Jun 32 daysCampbell Bradley LPresident and CEOSSale−7.50K$10.00−$75.0K−0.8%886.7K after10b5-1
May 3, 2024 (view filing)May 12 daysCampbell Bradley LPresident and CEOSSale−7.50K$10.07−$75.5K−0.8%886.7K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysCampbell Bradley LPresident and CEOSSale−7.50K$11.67−$87.5K−0.8%886.7K after10b5-1
Mar 15, 2024 (view filing)Jan 1065 daysCrowley John FExecutive ChairmanSSale−31.6K$13.65−$431.5K−3.3%927.0K afterAmended10b5-1
Mar 6, 2024 (view filing)Mar 4-52 daysMcGlynn Margaret GDirectorSSale−15.0K$13.35−$200.2K−20.2%59.3K after2 lots10b5-1
Mar 5, 2024 (view filing)Mar 14 daysCampbell Bradley LPresident and CEOSSale−15.8K$13.14−$208.0K−1.8%871.2K after10b5-1
Mar 5, 2024 (view filing)Mar 14 daysCrowley John FExecutive ChairmanSSale−29.2K$13.35−$389.6K−4.8%573.5K after10b5-1
Feb 20, 2024 (view filing)Feb 155 daysCampbell Bradley LPresident and CEOSSale−4.17K$14.00−$58.3K−0.5%871.2K after10b5-1
Feb 20, 2024 (view filing)Feb 155 daysClark David MichaelChief People OfficerSSale−4.43K$14.00−$62.0K−1.7%253.7K after10b5-1
Feb 20, 2024 (view filing)Feb 155 daysCrowley John FExecutive ChairmanSSale−31.6K$13.81−$436.6K−4.3%697.6K after10b5-1
Feb 8, 2024 (view filing)Feb 6-72 daysRosenberg EllenChief Legal OfficerSSale−30.0K$13.00−$390.0K−7.5%367.7K after2 lots10b5-1
Feb 5, 2024 (view filing)Feb 14 daysCampbell Bradley LPresident and CEOSSale−15.8K$12.56−$198.9K−1.8%875.4K after10b5-1
Feb 5, 2024 (view filing)Feb 14 daysCrowley John FExecutive ChairmanSSale−31.6K$12.62−$399.0K−4.0%750.8K after10b5-1
Jan 24, 2024 (view filing)Jan 222 daysCrowley John FExecutive ChairmanSSale−55.3K$12.36−$683.8K−6.6%782.5K after10b5-1
Jan 18, 2024 (view filing)Jan 162 daysCrowley John FExecutive ChairmanSSale−31.6K$12.78−$404.0K−3.6%837.8K after10b5-1
Jan 9, 2024 (view filing)Jan 8-91 dayClark David MichaelChief People OfficerSSale−10.1K$14.00−$141.5K−3.7%266.7K after2 lots10b5-1
Jan 9, 2024 (view filing)Jan 8-91 dayProut SamanthaChief Accounting OfficerSSale−32.1K$14.00−$449.5K−28.4%81.0K after2 lots10b5-1
Jan 4, 2024 (view filing)Jan 22 daysCampbell Bradley LPresident and CEOSSale−15.8K$14.23−$225.4K−1.6%947.8K after2 lots10b5-1
Jan 4, 2024 (view filing)Jan 22 daysRosenberg EllenChief Legal OfficerSSale−30.0K$14.21−$426.3K−8.1%342.3K after10b5-1
Dec 29, 2023 (view filing)Dec 281 dayCastelli JeffChief Development OfficerSSale−17.4K$14.52−$253.0K−4.9%340.7K after10b5-1
Dec 28, 2023 (view filing)Dec 262 daysProut SamanthaChief Accounting OfficerSSale−7.66K$14.00−$107.2K−5.9%121.9K after10b5-1
Dec 28, 2023 (view filing)Dec 26-272 daysRosenberg EllenChief Legal OfficerSSale−35.0K$14.01−$490.4K−9.3%342.3K after2 lots10b5-1
Dec 20, 2023 (view filing)Dec 19-201 dayCastelli JeffChief Development OfficerSSale−19.2K$13.24−$253.5K−5.1%358.1K after2 lots10b5-1
Dec 19, 2023 (view filing)Dec 154 daysCrowley John FExecutive ChairmanSSale−6.04K$12.66−$76.5K−0.7%877.7K after10b5-1
Dec 5, 2023 (view filing)Dec 14 daysCampbell Bradley LPresident and CEOSSale−11.7K$11.08−$129.7K−1.5%792.2K after10b5-1
Dec 5, 2023 (view filing)Dec 14 daysCrowley John FExecutive ChairmanSSale−6.04K$11.08−$67.0K−0.7%883.8K after10b5-1
Nov 17, 2023 (view filing)Nov 152 daysCrowley John FExecutive ChairmanSSale−6.04K$10.84−$65.5K−0.7%889.8K after10b5-1
Nov 3, 2023 (view filing)Nov 12 daysCampbell Bradley LPresident and CEOSSale−11.7K$10.97−$128.3K−1.5%792.2K after10b5-1
Nov 3, 2023 (view filing)Nov 12 daysCrowley John FExecutive ChairmanSSale−6.04K$10.97−$66.3K−0.7%895.9K after10b5-1
Oct 18, 2023 (view filing)Oct 162 daysCrowley John FExecutive ChairmanSSale−6.04K$10.50−$63.5K−0.7%901.9K after10b5-1